前者扩大了欧洲使用可植入装置的Foster-医疗聚合物的途径。 Formerra expands European access to Foster® medical polymers for implantable devices.

Formerra宣布达成新的分销协议，将向欧洲供应Foster®医疗化合物，扩大其面向医疗制造商的专用聚合物产品组合。 Formerra has announced a new distribution agreement to supply Foster® medical compounds across Europe, expanding its portfolio of specialized polymers for healthcare manufacturers. 这一伙伴关系将Foster的习惯、高性能材料——包括无线电卡片和符合六级USP的化合物——带给欧洲客户,支持诸如可植入装置等关键应用。 The partnership brings Foster’s custom, high-performance materials—including radiopaque and USP Class VI-compliant compounds—to European customers, supporting critical applications like implantable devices. 福梅拉将提供当地监管专业知识,物流和技术支持, 帮助客户满足复杂的欧洲标准. Formerra will provide local regulatory expertise, logistics, and technical support to help clients meet complex European standards. 这一举措以前台现有的GEONPVC和填充的PP材料分布为基础,反映了对先进、符合要求的医疗聚合物的需求日益增加。 The move builds on Formerra’s existing distribution of GEON® PVC and filled PP materials and reflects growing demand for advanced, compliant medical polymers. 2026年2月3日至5日将在加利福尼亚州阿纳海姆的MD&M West展示扩大的投资组合。 The expanded portfolio will be showcased at MD&M West in Anaheim, California, from February 3–5, 2026.